A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...
Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.
International: On Thursday, it said it had found 11 more women who had their uterus removed unnecessarily in 2022, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback